Integrating causal human genetics and In vivo transcriptomics to uncover a shared lipid-centric architecture in metabolic and neurocognitive disease

Key Points

• A high-confidence gene signature reflects lipid dysregulation—a common interface in both metabolic and neurocognitive diseases.
• The study identifies 13 key genes related to lipid dysregulation that could guide future therapeutic development efforts.
• Utilizing a multi-modal investigation, researchers integrate human genetics and in vivo transcriptomics for comprehensive insights.
• The findings imply a shared lipid-centric architecture, indicating potential pathways for treatment across different disease areas.